These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17453602)

  • 41. Attention-deficit/hyperactivity disorder and early-onset substance use disorders.
    Wilson JJ; Levin FR
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):751-63. PubMed ID: 16262592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Attention-deficit/hyperactivity disorder and substance abuse].
    Davids E; Gastpar M
    Psychiatr Prax; 2003 May; 30(4):182-6. PubMed ID: 12768521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring the relationship among ADHD, stimulants, and substance abuse.
    Nelson A; Galon P
    J Child Adolesc Psychiatr Nurs; 2012 Aug; 25(3):113-8. PubMed ID: 22830508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders.
    Levin FR
    J Clin Psychiatry; 2007; 68 Suppl 11():9-14. PubMed ID: 18307376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The course of attention deficit hyperactivity disorder (ADHD) over the life span].
    Koumoula A
    Psychiatriki; 2012 Jun; 23 Suppl 1():49-59. PubMed ID: 22796973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment].
    Paslakis G; Schredl M; Alm B; Sobanski E
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):444-51. PubMed ID: 23864520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stimulant treatment of ADHD and risk of sudden death in children.
    Vitiello B; Towbin K
    Am J Psychiatry; 2009 Sep; 166(9):955-7. PubMed ID: 19528196
    [No Abstract]   [Full Text] [Related]  

  • 49. Managing attention-deficit/hyperactivity disorder in children and adolescents.
    McClain EK; Burks EJ
    Prim Care; 2015 Mar; 42(1):99-112. PubMed ID: 25634708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustained and focused attention deficits in adult ADHD.
    Marchetta ND; Hurks PP; De Sonneville LM; Krabbendam L; Jolles J
    J Atten Disord; 2008 May; 11(6):664-76. PubMed ID: 17712171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adult Attention-Deficit Hyperactivity Disorder/Substance Use Disorder Dual Disorder Patients: A Dual Disorder Unit Point of View.
    Maremmani I; Spera V; Maiello M; Maremmani AGI; Perugi G
    Curr Top Behav Neurosci; 2022; 57():179-198. PubMed ID: 35507285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.
    Pliszka SR
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):525-40, vii. PubMed ID: 10944655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
    Pliszka SR
    J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Adult ADHD: clinical aspects and therapeutic implications].
    Ceraudo G; Vannucchi G; Perugi G; Dell'osso L
    Riv Psichiatr; 2012; 47(6):451-64. PubMed ID: 23160106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
    Groenman AP; Oosterlaan J; Rommelse N; Franke B; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Addiction; 2013 Aug; 108(8):1503-11. PubMed ID: 23506232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attention deficit hyperactivity disorder (ADHD) among illicit psychostimulant users: a hidden disorder?
    Kaye S; Darke S; Torok M
    Addiction; 2013 May; 108(5):923-31. PubMed ID: 23227816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Childhood attention deficit hyperactivity disorder and the development of substance use disorders: valid concern or exaggeration?
    Looby A
    Addict Behav; 2008 Mar; 33(3):451-63. PubMed ID: 18037571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.